Spesolimab Disease Interactions
There is 1 disease interaction with spesolimab.
Spesolimab (applies to spesolimab) infection
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Infection - Bacterial/Fungal/Protozoal/Viral
Spesolimab may increase the risk of infections and should not be initiated in patients having any active infection, including tuberculosis (TB), until it is appropriately treated and resolved. Patients should be evaluated for TB prior to treatment and anti-tuberculosis treatment should be considered in patients with latent TB or history of TB with unconfirmed adequate treatment. In patients with chronic or recurrent infections, risk and benefits of treatment with this drug should be carefully assessed. Patients receiving this drug should be advised to contact their health care provider if they have any signs or symptoms of infection during or after treatment.
References
- (2022) "Product Information. Spevigo (spesolimab)." Boehringer Ingelheim, 1
Spesolimab drug interactions
There are 152 drug interactions with spesolimab.
Report options
More about spesolimab
- spesolimab consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
